Terrie Curran - Feb 27, 2025 Form 4 Insider Report for Phathom Pharmaceuticals, Inc. (PHAT)

Role
President and Chief Executive, Director
Signature
/s/ Molly Henderson, Attorney-in-Fact for Terrie Curran
Stock symbol
PHAT
Transactions as of
Feb 27, 2025
Transactions value $
$0
Form type
4
Date filed
3/3/2025, 05:16 PM
Previous filing
Jan 23, 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PHAT Stock Option (Right to Buy) Award $0 +343K $0.00 343K Feb 27, 2025 Common Stock 343K $5.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option will vest with respect to 25% of the shares of common stock on February 27, 2026, and will vest with respect to the remaining shares in equal monthly installments over the following three years, subject to the reporting person's continuous service to the Company on the applicable vesting dates.